• Journal of Ginseng Research
• /
• 제47권6호
• /
• pp.726-734
• /
• 2023

Background: Skeletal muscles play a key role in physical activity and energy metabolism. The loss of skeletal muscle mass can cause problems related to metabolism and physical activity. Studies are being conducted to prevent such diseases by increasing the mass and regeneration capacity of muscles. Ginsenoside Rg5 has been reported to exhibit a broad range of pharmacological activities. However, studies on the effects of Rg5 on muscle differentiation and growth are scarce. Methods: To investigate the effects of Rg5 on myogenesis, C2C12 myoblasts were induced to differentiate with Rg5, followed by immunoblotting, immunostaining, and qRT-PCR for myogenic markers and promyogenic signaling (p38MAPK). Immunoprecipitation confirmed that Rg5 increased the interaction between MyoD and E2A via p38MAPK. To investigate the effects of Rg5 on prevention of muscle mass loss, C2C12 myotubes were treated with dexamethasone to induce muscle atrophy. Immunoblotting, immunostaining, and qRT-PCR were performed for myogenic markers, Akt/mTOR signaling for protein synthesis, and atrophy-related genes (Atrogin-1 and MuRF1). Results: Rg5 promoted C2C12 myoblast differentiation through phosphorylation of p38MAPK and MyoD/E2A heterodimerization. Furthermore, Rg5 stimulated C2C12 myotube hypertrophy via phosphorylation of Akt/mTOR. Phosphorylation of Akt induces FoxO3a phosphorylation, which reduces the expression of Atrogin-1 and MuRF1. Conclusion: This study provides an understanding of how Rg5 promotes myogenesis and hypertrophy and prevents dexamethasone-induced muscle atrophy. The study is the first, to the best of our knowledge, to show that Rg5 promotes muscle regeneration and to suggest that Rg5 can be used for therapeutic intervention of muscle weakness and atrophy, including cancer cachexia.

• 대한화장품학회지
• /
• 제30권2호
• /
• pp.235-240
• /
• 2004

해양 천연물 유래의 신규 광노화 방지소재의 개발을 위해 항산화 활성과 matrix metalloproteinase-1 (MMP-1) 발현 억제활성을 갖는 잘피(Zostera marina L.)를 선별하였다. 에탄올 추출물로부터 3개의 화합물(compound 1과 2, 3)을 분리하였으며 각각 apigenin-7-O-$\beta$-D-glucoside (1)과 chrysoeriol (2), luteolin (3)으로 동정하였다. 이 화합물들은 1,1-diphenyl-2-picryl-hydrazyl radical에 대하여 각각 0,18mM과 0.68mM, 0.01mM의 $SC_{50}$/ 값을 나타내었으며, xanthine과 xanthine oxidase의 반응으로 생성되는 superoxide radical에 대하여 각각 0.04mM과 0.03mM, 0.01mM의 $SC_{50}$/ 값을 나타내었다. 특히 compound 3은 MMP-1에 대해 35.0$\mu$M의 농도에서 44% 이상의 발현 억제황성을 나타내었으며 MMP-1 발현을 유도하는 신호전달물질로 알려 있는 interleukin 6의 생성도 억제하였다. 또한 잘피 추출물을 함유한 제품이 주름 개선효과를 측정하였다. 추출물을 3.0% 함유한 크림을 8주간 적용하여 미세주름과 피부거칠음의 현저한 개선효과를 확인하였다. 결론적으로, 잘피 추출물에서 분리된 화합물들은 우수한 항산화 활성과 MMP-1 발현 억제활성을 가지며, 이 추출물을 함유한 제품은 피부주름의 감소효과를 나타내었다. 따라서, 잘피 추출물은 화장품의 새로운 항노화 소재로서 적용될 수 있을 것이다.

• 한국전문물리치료학회지
• /
• 제26권3호
• /
• pp.67-75
• /
• 2019

Background: Stress urinary incontinence (SUI) is an involuntary leakage of urine from the urethra when intra-abdominal pressure increases, such as from sneezing, coughing, or physical exertion. It is caused by insufficient strength of the pelvic floor and sphincter muscles, resulting from vaginal delivery, obesity, hard physical work, or aging. The pelvic floor electrical stimulator is a conservative treatment generally used to relieve the symptoms of urinary incontinence. it recommended to applied before surgery is performed. Objects: The purpose of this study was to determine if the transcutaneous electrical stimulation (TCES) would be effective for the physiological symptoms and psychological satisfaction of women with SUI for an 8-weeks intervention. Methods: Easy-K is a specially designed user-friendly TCES. Five female who were diagnosed with SUI by a gynecologist but who did not require surgical intervention were included in this study. Intervention was implemented over an 8-week period. Outcome measures included vaginal ultrasonography, Levator ani muscle (LAM) contraction strength, incontinence quality of life (I-QOL), and female sexual function index (FSFI) questionnaires. Results: The bladder neck position significantly decreased across assessment time. Funneling index and urethral width significantly decreased after 8 weeks of intervention (p<.05). The bladder necksymphyseal distance and posterior rhabdosphincter thickness statistically increased and the anterior rhabdosphincter thickness showed a tendency to increase. All participants demonstrated a significant increase in the LAM contraction score across three assessment times (p<.05). Although the total score of the I-QOL did not show significant improvement, it steadily increased and among I-QOL subscales, only the "avoidance" subscale showed statistical improvements (p<.05). The total score of the FSFI statistically improved and the "desire" score significantly changed (p<.05). Conclusion: The TCES is recommended for women who want to apply conservative treatments before surgery and who have suffered from SUI in aspects of sexual function and quality of life.